Authors: Meghna Rao
The Centers for Disease Control and Prevention (CDC) recommends that individuals with autoimmune diseases and those with weakened immune systems receive the COVID-19 vaccines; however, no solid data are currently available regarding their safety specifically in populations with autoimmune conditions.1 On the other hand, researchers have indicated that patients with autoimmune and inflammatory conditions vs the general population may be at increased risk for COVID-19-associated hospitalizations and worse disease outcomes, suggesting that the benefits of vaccination outweigh the risks.2 In February 2021, the American College of Rheumatology (ACR) also released detailed clinical guidance for providers regarding COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases.3
For More Information: https://www.rheumatologyadvisor.com/home/general-rheumatology/covid19-vaccination-vaccines-autoimmune-diseases-perspectives-concerns-expectations/